A Mutagenesis Study of the Putative Luciferin Binding Site Residues of Firefly Luciferase†

Biochemistry ◽  
2003 ◽  
Vol 42 (35) ◽  
pp. 10429-10436 ◽  
Author(s):  
Bruce R. Branchini ◽  
Tara L. Southworth ◽  
Martha H. Murtiashaw ◽  
Henrik Boije ◽  
Sarah E. Fleet
Biochemistry ◽  
2004 ◽  
Vol 43 (38) ◽  
pp. 12322-12330 ◽  
Author(s):  
Blanca Barquera ◽  
Mark J. Nilges ◽  
Joel E. Morgan ◽  
Leticia Ramirez-Silva ◽  
Weidong Zhou ◽  
...  

1982 ◽  
Vol 35 (6) ◽  
pp. 857-861 ◽  
Author(s):  
Mary S. Rosendahl ◽  
Nelson J. Leonard ◽  
Marlene Deluca

2012 ◽  
Vol 2012 ◽  
pp. 1-12 ◽  
Author(s):  
Marlet Martinez-Archundia ◽  
Arnau Cordomi ◽  
Pere Garriga ◽  
Juan J. Perez

The present study reports the results of a combined computational and site mutagenesis study designed to provide new insights into the orthosteric binding site of the human M3 muscarinic acetylcholine receptor. For this purpose a three-dimensional structure of the receptor at atomic resolution was built by homology modeling, using the crystallographic structure of bovine rhodopsin as a template. Then, the antagonist N-methylscopolamine was docked in the model and subsequently embedded in a lipid bilayer for its refinement using molecular dynamics simulations. Two different lipid bilayer compositions were studied: one component palmitoyl-oleyl phosphatidylcholine (POPC) and two-component palmitoyl-oleyl phosphatidylcholine/palmitoyl-oleyl phosphatidylserine (POPC-POPS). Analysis of the results suggested that residues F222 and T235 may contribute to the ligand-receptor recognition. Accordingly, alanine mutants at positions 222 and 235 were constructed, expressed, and their binding properties determined. The results confirmed the role of these residues in modulating the binding affinity of the ligand.


Biochemistry ◽  
1991 ◽  
Vol 30 (12) ◽  
pp. 3049-3054 ◽  
Author(s):  
Rudi Glockshuber ◽  
Joerg Stadlmueller ◽  
Andreas Plueckthun

2004 ◽  
Vol 101 (1) ◽  
pp. 235-237 ◽  
Author(s):  
Nicholas P. Franks ◽  
William R. Lieb ◽  
Srinivasa N. Raja

Most proteins are insensitive to the presence of general anaesthetics at concentrations which induce anaesthesia, while some are inhibited by some agents but not others. Here we show that, over a 100000-fold range of potencies, the activity of a pure soluble protein (firefly luciferase) can be inhibited by 50% at anaesthetic concentrations which are essentially identical to those which anaesthetize animals. This identity holds for inhalational agents (such as halothane, methoxyflurane and chloroform), aliphatic and aromatic alcohols, ketones, ethers and alkanes. This finding is all the more striking in view of the fact that the inhibition is shown to be competitive in nature, with anaesthetic molecules competing with the substrate (luciferin) molecules for binding to the protein. We show that the anaesthetic-binding site can accommodate only one large, but more than one small, anaesthetic molecule. The obvious mechanism suggested by our results is that general anaesthetics, despite their chemical and structural diversity, act by competing with endogenous ligands for binding to specific receptors.


Sign in / Sign up

Export Citation Format

Share Document